Dr. Bienkowska is a Sr. Director and Head of Computational Biology at Pfizer in Oncology Research and Development. The team led by Dr. Bienkowska is responsible for computational aspects of projects from early discovery through late stage clinical development in Oncology. Responsibilities include development and implementation of strategies for biomarkers/target identification and patient selection through cutting edge, integrative analysis of large-scale data from preclinical models, patient registries and clinical trials in collaboration with discovery and clinical teams. Dr. Bienkowska has deep expertise in developing and applying NGS-based technologies to target discovery and investigations of mechanisms of resistance in clinical trials in therapeutic areas spanning Oncology, Immunology and Neurology. Dr. Bienkowska actively collaborates with academic groups developing novel NGS and computational technologies. Her academic appointments include: Adjunct Professor in the Department of Medicine, Genetics at UCSD, Visiting Scientist at CSAIL, MIT and Adjunct Professor in Biomedical Engineering Department at Boston University. Dr. Bienkowska has PhD degree in Physics from the University of Chicago and completed postdoctoral training at Harvard and Dana Farber Cancer Institute in Biological Chemistry and Molecular Pharmacology.